ACLY and neoplasm: Inhibiting key enzymes such as fatty acid synthase (FASN) or acetyl-CoA carboxylase (ACLY) can reduce the energy supply of tumor cells, while potentially increasing immune cell attacks on tumors, providing new strategies for cancer treatment (118, 119).